Company intelligence / Profile preview

InnoCom Bio Equities

San Francisco, California, United Statesinnocombio.com ↗

Ownership: Private
Development stage: Other

Overview

InnoCom Bio Equities is a California-based investment management and advisory firm focused on early-stage life sciences companies. It provides venture capital, infrastructure development, and executive advisory services to help emerging biotech ventures transition from grant funding through pre-clinical and early clinical phases toward licensing or acquisition by larger pharmaceutical firms. The firm manages multiple funds and special purpose vehicles targeting high-potential innovations in both human and veterinary health sectors[1][2][5][6].

Industry: Investors

Partnerships

Relationships with Big Pharma for licensing opportunities for portfolio companies

Beyond the preview

Go deeper on InnoCom Bio Equities.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoCom Bio Equities.

Explore the full profile